BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28051121)

  • 1. Global Prioritizing Disease Candidate lncRNAs via a Multi-level Composite Network.
    Yao Q; Wu L; Li J; Yang LG; Sun Y; Li Z; He S; Feng F; Li H; Li Y
    Sci Rep; 2017 Jan; 7():39516. PubMed ID: 28051121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemically identifying and prioritizing risk lncRNAs through integration of pan-cancer phenotype associations.
    Xu C; Qi R; Ping Y; Li J; Zhao H; Wang L; Du MY; Xiao Y; Li X
    Oncotarget; 2017 Feb; 8(7):12041-12051. PubMed ID: 28076842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying the crosstalk of dysfunctional pathways mediated by lncRNAs in breast cancer subtypes.
    Wang L; Li J; Zhao H; Hu J; Ping Y; Li F; Lan Y; Xu C; Xiao Y; Li X
    Mol Biosyst; 2016 Mar; 12(3):711-20. PubMed ID: 26725846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncDisAP: a computation model for LncRNA-disease association prediction based on multiple biological datasets.
    Wang Y; Juan L; Peng J; Zang T; Wang Y
    BMC Bioinformatics; 2019 Dec; 20(Suppl 16):582. PubMed ID: 31787106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncSubpathway: a novel approach for identifying dysfunctional subpathways associated with risk lncRNAs by integrating lncRNA and mRNA expression profiles and pathway topologies.
    Xu Y; Li F; Wu T; Xu Y; Yang H; Dong Q; Zheng M; Shang D; Zhang C; Zhang Y; Li X
    Oncotarget; 2017 Feb; 8(9):15453-15469. PubMed ID: 28152521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting lncRNA-disease associations using network topological similarity based on deep mining heterogeneous networks.
    Zhang H; Liang Y; Peng C; Han S; Du W; Li Y
    Math Biosci; 2019 Sep; 315():108229. PubMed ID: 31323239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CNNDLP: A Method Based on Convolutional Autoencoder and Convolutional Neural Network with Adjacent Edge Attention for Predicting lncRNA-Disease Associations.
    Xuan P; Sheng N; Zhang T; Liu Y; Guo Y
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a lncRNA-PCG bipartite network and identification of cancer-related lncRNAs: a case study in prostate cancer.
    Liu Y; Zhang R; Qiu F; Li K; Zhou Y; Shang D; Xu Y
    Mol Biosyst; 2015 Feb; 11(2):384-93. PubMed ID: 25385343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer.
    Li Y; Chen J; Zhang J; Wang Z; Shao T; Jiang C; Xu J; Li X
    Oncotarget; 2015 Sep; 6(28):25003-16. PubMed ID: 26305674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating Multiple Heterogeneous Networks for Novel LncRNA-Disease Association Inference.
    Zhang J; Zhang Z; Chen Z; Deng L
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(2):396-406. PubMed ID: 28489543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prioritizing candidate disease-related long non-coding RNAs by walking on the heterogeneous lncRNA and disease network.
    Zhou M; Wang X; Li J; Hao D; Wang Z; Shi H; Han L; Zhou H; Sun J
    Mol Biosyst; 2015 Mar; 11(3):760-9. PubMed ID: 25502053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four lncRNAs associated with breast cancer prognosis identified by coexpression network analysis.
    Li J; Gao C; Liu C; Zhou C; Ma X; Li H; Li J; Wang X; Qi L; Yao Y; Zhang X; Zhuang J; Liu L; Wang K; Sun C
    J Cell Physiol; 2019 Aug; 234(8):14019-14030. PubMed ID: 30618123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
    Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
    Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A network based method for analysis of lncRNA-disease associations and prediction of lncRNAs implicated in diseases.
    Yang X; Gao L; Guo X; Shi X; Wu H; Song F; Wang B
    PLoS One; 2014; 9(1):e87797. PubMed ID: 24498199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA ontology: inferring lncRNA functions based on chromatin states and expression patterns.
    Li Y; Chen H; Pan T; Jiang C; Zhao Z; Wang Z; Zhang J; Xu J; Li X
    Oncotarget; 2015 Nov; 6(37):39793-805. PubMed ID: 26485761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and analysis of dysregulated lncRNA-associated ceRNA network identified novel lncRNA biomarkers for early diagnosis of human pancreatic cancer.
    Zhou M; Diao Z; Yue X; Chen Y; Zhao H; Cheng L; Sun J
    Oncotarget; 2016 Aug; 7(35):56383-56394. PubMed ID: 27487139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associating lncRNAs with small molecules via bilevel optimization reveals cancer-related lncRNAs.
    Wang Y; Chen S; Chen L; Wang Y
    PLoS Comput Biol; 2019 Dec; 15(12):e1007540. PubMed ID: 31877126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
    Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
    J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNAs and complex diseases: from experimental results to computational models.
    Chen X; Yan CC; Zhang X; You ZH
    Brief Bioinform; 2017 Jul; 18(4):558-576. PubMed ID: 27345524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers.
    Zhang Y; Xu Y; Feng L; Li F; Sun Z; Wu T; Shi X; Li J; Li X
    Oncotarget; 2016 Sep; 7(39):64148-64167. PubMed ID: 27580177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.